Paracetamol/Ibuprofen Viatris (Ibuprofen, Paracetamol)

Paracetamol/Ibuprofen Viatris combines ibuprofen and paracetamol to address pain and inflammation pathways in several common conditions.

• Headache: provides rapid relief of mild to moderate headache pain.
• Dental pain: reduces postoperative dental discomfort and swelling.
• Musculoskeletal pain: alleviates pain and inflammation associated with sprains, strains and minor injuries.
• Fever: lowers elevated body temperature in febrile adults and children.
• Menstrual cramps: eases dysmenorrhea‑related pelvic pain.
• Osteoarthritis (mild): helps manage intermittent joint pain in early‑stage osteoarthritis.

• Ibuprofen inhibits cyclo‑oxygenase (COX‑1 and COX‑2) enzymes, decreasing prostaglandin synthesis and thereby reducing inflammation, pain and fever. Paracetamol acts centrally by inhibiting a variant of the COX enzyme and modulating serotonergic pathways, which elevates the pain‑threshold and produces antipyretic effects. The combined action provides additive analgesic and antipyretic activity without a single shared receptor target.

Paracetamol/Ibuprofen Viatris may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Nausea: mild stomach upset that often resolves without treatment.
• Dyspepsia: occasional indigestion or heartburn.
• Headache: transient headache may occur despite analgesic intent.
• Dizziness: brief episodes of light‑headedness.
• Rash: mild skin redness or itching.
• Elevated liver enzymes: mild, asymptomatic increase detected on routine labs.

Serious or Rare Side Effects

• Gastrointestinal bleeding: ulceration or bleeding in the stomach or intestines.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Hepatotoxicity: significant liver injury, especially with overdose.
• Renal impairment: reduced kidney function or acute kidney injury.
• Anaphylaxis: rare, potentially life‑threatening allergic reaction.
• Cardiovascular events: increased risk of heart attack or stroke with prolonged high‑dose use.

When prescribing Paracetamol/Ibuprofen Viatris, clinicians should consider several safety aspects.

• Assess renal function: adjust use in patients with impaired kidney function.
• Monitor liver enzymes: avoid in patients with active liver disease or chronic alcohol use.
• Avoid in third‑trimester pregnancy: risk of fetal complications.
• Use caution in asthma: ibuprofen may trigger bronchospasm in susceptible individuals.
• Review concomitant NSAID or acetaminophen use: limit total daily dose to prevent toxicity.
• Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Paracetamol/Ibuprofen Viatris can interact with several medicines, requiring attention to dosage and monitoring.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased risk of bleeding.
• High‑dose aspirin: heightened gastrointestinal toxicity.
• Lithium: ibuprofen may raise serum lithium levels, risking toxicity.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: may reduce renal perfusion, especially in volume‑depleted patients.
• Diuretics: combined effect can impair kidney function.
• Selective serotonin reuptake inhibitors (SSRIs): modest increase in bleeding risk.
• Methotrexate: ibuprofen can decrease clearance, raising toxicity potential.